Johnson & Johnson Innovation invites groundbreakers to submit ideas aimed at reducing the burden and disability caused by serious neuropsychiatric, neurological and neurodegenerative diseases in the NYC Innovation QuickFire Challenge on Neuroscience.
The groundbreaker(s) with the best idea(s) will receive up to $25,000 in grant funding; one year of residency at JLABS @ NYC – with the use of a bench, workstation and access to the JLABS @ NYC community; and mentorship from experts at the Johnson & Johnson Family of Companies.
JLABS @ NYC — a 30,000-square foot facility located at the New York Genome Center —supports the next generation of innovation leaders by enabling and encouraging early-stage companies aiming to transform the science of today into the breakthrough healthcare potential solutions of tomorrow.
By applying the unique Johnson & Johnson Innovation – JLABS model to New York’s dynamic, entrepreneurial spirit, JLABS @ NYC aims to convene the brightest talent from around the region with industry experts to push the boundaries of science and collaborate across a shared community.
Since its launch in 2018, JLABS @ NYC has welcomed 46 resident companies to its family across the pharmaceutical, medical device, health tech, and consumer sectors. With the continuous need to help advance science with the aim to conquer our world’s evolving health challenges, JLABS @ NYC is actively searching for the brightest minds with transformative ideas on how to improve health and wellness – and we believe that the next big breakthroughs in healthcare could begin within academia and this rising generation of innovators.
Up to $25,000 in grant funding
One year of residency at JLABS @ NYC – with the use of a bench, workstation and access to the JLABS @ NYC community
Mentorship from experts from the Johnson & Johnson Family of Companies.
We encourage applications from neuroscience groundbreakers working on projects related to target identification, target validation or measurements that help patient selection or treatment response to support the discovery and development of breakthrough therapies for neuropsychiatric, neurological and neurodegenerative diseases, with a particular interest in the following areas:
- Neuropsychiatric diseases, including behavioral domains (e.g. anhedonia, anxiety and sleep) that are commonly dysregulated in serious mental illnesses.
- Neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease and ALS using small molecule approaches as well as alternative modalities (e.g. gene therapy, ASO and siRNA).
- Approaches that advance understanding of neuroimmunology with potential to create new therapeutic avenues to modulate neuroinflammation.
- Digital biomarkers and therapeutics to improve patient outcomes and support precision central nervous system medicine approaches.
Application process
Potential solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:
- Uniqueness of the idea
- Potential impact on human health, with a specific focus on inclusive innovations
- Feasibility of the idea
- Thoroughness of approach
- Use of JLABS @ NYC residency and potential impact on the New York City ecosystem
Why this challenge matters to us
At Johnson & Johnson Innovation, we believe a good idea can come from anywhere, and it’s our goal to find new and innovative technologies that aim to provide solutions to patients from across the world. Working together, we can spark the next great idea that can potentially change the trajectory of health.
Do you want to stay updated about latest opportunities, scholarships & online competitions, like NYC Innovation Quickfire Challenge On Neuroscience then please install our Android or iOS App here.
Awards:-
Up to $25,000 in grant funding
One year of residency at JLABS @ NYC – with the use of a bench, workstation and access to the JLABS @ NYC community
Mentorship from experts from the Johnson & Johnson Family of Companies
Deadline:- 12-02-2021
